Pro-Dex Completes Acquisition of Advanced Precision Machining

Pro-Dex ( (PDEX) ) has provided an announcement.

On February 9, 2026, Pro-Dex, Inc. completed the acquisition of Advanced Precision Machining LLC, a Costa Mesa, California-based manufacturer of machined components that serves medical device, aerospace, defense, and U.S. Government customers, making APM a wholly owned subsidiary. The deal, valued at approximately $8.65 million and funded largely with a new $6.65 million term loan from UMB Bank plus a subordinated seller note, brings in-house a long-standing supplier that already produces several of Pro-Dex’s machined sub-assemblies.

As part of the transaction, Pro-Dex plans to operate APM independently, retain APM co-owner Sean McCaig as a consultant through 2026, and leverage APM’s automation and technology to streamline manufacturing and assembly in Irvine. The acquisition supports Pro-Dex’s expansion plans tied to an earlier contract extension with its largest customer, is expected to contribute to future revenue growth, and may lead to later reporting of consolidated financial results due to APM’s longer accounting close, while also positioning the company to sustain and grow APM’s aerospace, defense, and U.S. Government contracting business.

The most recent analyst rating on (PDEX) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on Pro-Dex stock, see the PDEX Stock Forecast page.

Spark’s Take on PDEX Stock

According to Spark, TipRanks’ AI Analyst, PDEX is a Neutral.

The score is driven primarily by solid recent profitability and improving leverage, supported by a reasonable P/E valuation. Offsetting factors are volatile cash flow conversion (including a negative annual period) and muted/weak technical momentum, while the major-customer contract extension provides a meaningful positive stabilizer.

To see Spark’s full report on PDEX stock, click here.

More about Pro-Dex

Pro-Dex, Inc. is a medical technology manufacturer specializing in the design, development, and production of autoclavable, battery-powered and electric multi-function surgical drivers and shavers used primarily in orthopedic, thoracic, and maxillofacial markets. The company, which also offers engineering, quality, and regulatory consulting services and sells rotary air motors to various industries, focuses mainly on serving medical device distributors as its core customer base.

Its proprietary technologies include patented adaptive torque-limiting software and specialized sealing solutions that enhance the performance and reliability of its surgical tools. While Pro-Dex’s rotary air motor business is described as a de minimis portion of overall operations, the company’s strategic emphasis remains on advanced surgical instrumentation and related services for regulated healthcare markets.

Average Trading Volume: 29,644

Technical Sentiment Signal: Buy

Current Market Cap: $119.7M

For an in-depth examination of PDEX stock, go to TipRanks’ Overview page.